It's been one month since your post. XBI is up a bit over 1% since then while the S&P is down just under 1% as I type We still don't know whether the current downsized FDA is good or bad for the industry, or good for some and bad for others (as might be the case with a lower bar for approval where there is more competition for existing products but easier to cross the finish line and reach the market). But it certainly seems it was, and probably still is, too soon to know for sure and jump to any conclusions good or bad yet